These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11390004)

  • 41. Eligibility for low-dose computerized tomography screening among asbestos-exposed individuals.
    Fitzgerald NR; Flanagan WM; Evans WK; Miller AB;
    Scand J Work Environ Health; 2015 Jul; 41(4):407-12. PubMed ID: 25837734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
    Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA
    Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening for Wilms tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model.
    McNeil DE; Brown M; Ching A; DeBaun MR
    Med Pediatr Oncol; 2001 Oct; 37(4):349-56. PubMed ID: 11568898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range?
    Anderson R; Haas M; Shanahan M
    Aust N Z J Public Health; 2008 Feb; 32(1):43-52. PubMed ID: 18290913
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Program-specific cost-effectiveness analysis: breast cancer screening policies for a safety-net program.
    Melnikow J; Tancredi DJ; Yang Z; Ritley D; Jiang Y; Slee C; Popova S; Rylett P; Knutson K; Smalley S
    Value Health; 2013; 16(6):932-41. PubMed ID: 24041343
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness.
    Goulart BH; Bensink ME; Mummy DG; Ramsey SD
    J Natl Compr Canc Netw; 2012 Feb; 10(2):267-75. PubMed ID: 22308519
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Preliminary specification of X-ray CT for lung cancer screening (LSCT) and its evaluation on risk-cost-effectiveness].
    Iinuma T; Tateno Y; Matsumoto T; Yamamoto S; Matsumoto M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Feb; 52(2):182-90. PubMed ID: 1561058
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomography.
    Lopci E; Castello A; Morenghi E; Tanzi D; Cavuto S; Lutman F; Chiesa G; Vanni E; Alloisio M; Infante M
    Nucl Med Commun; 2019 May; 40(5):508-516. PubMed ID: 30875336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of using electron beam computed tomography to identify patients at risk for clinical coronary artery disease.
    O'Malley PG; Greenberg BA; Taylor AJ
    Am Heart J; 2004 Jul; 148(1):106-13. PubMed ID: 15215799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cervical spine screening with CT in trauma patients: a cost-effectiveness analysis.
    Blackmore CC; Ramsey SD; Mann FA; Deyo RA
    Radiology; 1999 Jul; 212(1):117-25. PubMed ID: 10405730
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.
    Bolondi L; Sofia S; Siringo S; Gaiani S; Casali A; Zironi G; Piscaglia F; Gramantieri L; Zanetti M; Sherman M
    Gut; 2001 Feb; 48(2):251-9. PubMed ID: 11156649
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The costs and effects of cervical and breast cancer screening in a public hospital emergency room. The Cancer Control Center of Harlem.
    Mandelblatt J; Freeman H; Winczewski D; Cagney K; Williams S; Trowers R; Tang J; Gold K; Lin TH; Kerner J
    Am J Public Health; 1997 Jul; 87(7):1182-9. PubMed ID: 9240110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic screening for Chlamydia trachomatis: estimating cost-effectiveness using dynamic modeling and Dutch data.
    de Vries R; van Bergen JE; de Jong-van den Berg LT; Postma MJ;
    Value Health; 2006; 9(1):1-11. PubMed ID: 16441519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of positron emission tomography for the management of potentially operable non-small cell lung cancer in Quebec.
    Nguyen VH; Peloquin S; Lacasse Y
    Can Respir J; 2005; 12(1):19-25. PubMed ID: 15776130
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of sputum cytology in the diagnosis of lung cancer: a cost-effectiveness analysis.
    Raab SS; Hornberger J; Raffin T
    Chest; 1997 Oct; 112(4):937-45. PubMed ID: 9377956
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocellular carcinoma screening in patients waiting for liver transplantation: a decision analytic model.
    Saab S; Ly D; Nieto J; Kanwal F; Lu D; Raman S; Amado R; Nuesse B; Durazo F; Han S; Farmer DG; Ghobrial RM; Yersiz H; Chen P; Schwegel K; Goldstein LI; Tong M; Busuttil RW
    Liver Transpl; 2003 Jul; 9(7):672-81. PubMed ID: 12827551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
    Cipriano LE; Rupar CA; Zaric GS
    Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Screen-and-treat strategies for albuminuria to prevent cardiovascular and renal disease: cost-effectiveness of nationwide and targeted interventions based on analysis of cohort data from the Netherlands.
    Boersma C; Gansevoort RT; Pechlivanoglou P; Visser ST; van Toly FF; de Jong-van den Berg LT; de Jong PE; Postma MJ;
    Clin Ther; 2010 Jun; 32(6):1103-21. PubMed ID: 20637965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early lung cancer action project: a summary of the findings on baseline screening.
    Henschke CI; McCauley DI; Yankelevitz DF; Naidich DP; McGuinness G; Miettinen OS; Libby D; Pasmantier M; Koizumi J; Altorki N; Smith JP
    Oncologist; 2001; 6(2):147-52. PubMed ID: 11306726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Feasibility of a screening programme for lung cancer in former asbestos workers.
    Mastrangelo G; Ballarin MN; Bellini E; Bizzotto R; Zannol F; Gioffrè F; Gobbi M; Tessadri G; Marchiori L; Marangi G; Bozzolan S; Lange JH; Valentini F; Spolaore P
    Occup Med (Lond); 2008 May; 58(3):175-80. PubMed ID: 18346953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.